Chinese Diabetes Tracking Device Maker Raises Series C Round From CICC Capital

Login to View

Hangzhou Kang Sheng Health Management Consulting Co., a Chinese firm offering diabetes management equipment, has completed a US$100 million series C financing round, totaling from a series C1 and C2 round, according to a today’s statement.

Continue reading with a China Money Network subscription

Join Now

Already have an account or paid subscription? Log in